<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT924-5905</title>
	</head>
	<body>
		<main>
			<p>921124 FT  24 NOV 92 / International Capital Markets: Upjohn forms marketing link UPJOHN, the US pharmaceuticals group, and Boehringer Ingelheim of Germany, have agreed to develop and market four compounds discovered by the German drugs group. The compounds are all designed to treat central nervous system disorders in which Upjohn has considerable expertise. By co-developing the products with Upjohn, Boehringer will increase the likelihood and speed of licensing in the US, the world's largest market.</p>
		</main>
</body></html>
            